Ceftriaxone is a broad-spectrum antibiotic belonging to the third-generation cephalosporin class. It is primarily used to treat a variety of bacterial infections.
What infections does ceftriaxone treat?
Ceftriaxone is effective against numerous bacterial pathogens and is used for conditions such as lower respiratory tract infections like pneumonia, skin and soft tissue infections, urinary tract infections, complicated intra-abdominal infections, and bone and joint infections. It is also a treatment option for gonorrhea, pelvic inflammatory disease, and certain types of meningitis [1]. Additionally, it can be used to prevent infections in surgical patients [1].
How is ceftriaxone administered?
Ceftriaxone is administered intravenously or intramuscularly. The specific dosage and duration of treatment depend on the type and severity of the infection, as well as the patient's age and kidney function [1].
What are the potential side effects of ceftriaxone?
Common side effects associated with ceftriaxone include diarrhea, nausea, vomiting, rash, and injection site pain or redness. More serious, though less common, side effects can include allergic reactions, liver problems, and blood disorders [1].
Are there any contraindications for ceftriaxone use?
Ceftriaxone should not be used in patients with a known hypersensitivity to ceftriaxone, other cephalosporins, or penicillins. Caution is also advised in patients with severe kidney or liver impairment, as well as in newborns with hyperbilirubinemia [1].
What is the mechanism of action for ceftriaxone?
As a cephalosporin, ceftriaxone works by inhibiting bacterial cell wall synthesis. It binds to penicillin-binding proteins (PBPs) in the bacterial cell wall, preventing the cross-linking of peptidoglycan. This disruption weakens the cell wall, leading to bacterial cell lysis and death [1].
When does ceftriaxone patent exclusivity expire?
Information regarding specific patent expiry dates for ceftriaxone can be found on resources like DrugPatentWatch.com, which tracks pharmaceutical patent information and exclusivity periods for various drugs [2].
Who manufactures ceftriaxone?
Ceftriaxone is available as a generic medication, meaning it is manufactured by multiple pharmaceutical companies. While originator brands may have existed, generic versions are widely produced and distributed globally.
How does ceftriaxone compare to other antibiotics?
Ceftriaxone's efficacy and spectrum of activity place it among the widely used third-generation cephalosporins. Compared to earlier generations, it generally exhibits a broader spectrum against Gram-negative bacteria and improved stability against beta-lactamases. Its use is guided by local resistance patterns and the specific pathogen identified [1].
What are the risks of antibiotic resistance with ceftriaxone?
The overuse and misuse of antibiotics, including ceftriaxone, contribute to the development of antibiotic resistance. This means that bacteria can become less susceptible or entirely resistant to the drug, making infections harder to treat [3].
Sources
1. National Institutes of Health. (n.d.). Ceftriaxone. Retrieved from https://medlineplus.gov/druginfo/meds/a683000.html
2. DrugPatentWatch.com. (n.d.). Ceftriaxone. Retrieved from https://drugpatentwatch.com/
3. Centers for Disease Control and Prevention. (n.d.). Antibiotic Resistance. Retrieved from https://www.cdc.gov/drugresistance/about.html